Fennec Pharmaceuticals Inc. Common Stock is a Canadian biopharmaceutical company. They specialize in developing innovative cancer treatments and are committed to improving the lives of patients with limited treatment options. Their cutting-edge research and dedication to drug development make them a key player in the pharmaceutical industry.
